IT Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on IT Press Releases.

Press releases published on September 9, 2026

Sep. 9, 2026

Electra Therapeutics Appoints Chris Clark, CFA, to Chief Financial Officer

Indeterminate GlobeNewswire

Sep. 9, 2026

Serina Therapeutics Reports Cohort 1 Observations from SER-252 Registrational Study in Advanced Parkinson’s Disease and Advances to Cohort 2

Indeterminate GlobeNewswire

Sep. 9, 2026

American Academy of Neurology onboards Marvix AI to its Practice Success Network to bring ambient AI to thousands of neurologists

Indeterminate GlobeNewswire

Sep. 9, 2026

Rail Vision Introduces TrackScout and YardFlow Flex as New Brand Names for its Mainline and Switchyard Solutions

Indeterminate GlobeNewswire

Sep. 9, 2026

NervGen to Host Inaugural R&D Day on September 30, 2026

Indeterminate GlobeNewswire

Sep. 9, 2026

Helus Pharma to Participate at the H.C. Wainwright 28th Annual Global Investment Conference in New York

Indeterminate GlobeNewswire

Sep. 9, 2026

Context Therapeutics Announces First Patient Dosed in Phase 1 Trial of CT-202

Indeterminate GlobeNewswire

Sep. 9, 2026

Avicanna Launches MyMedi.ca Integrated Healthcare Program in Canada

Indeterminate GlobeNewswire

Sep. 9, 2026

America's Car-Mart Reports First Quarter Fiscal Year 2027 Results

Indeterminate GlobeNewswire

Sep. 9, 2026

Kane Biotech to Host Commercial Update Webcast on September 16

Indeterminate GlobeNewswire

Sep. 9, 2026

Bilibili Inc. Announces Completion of US$500 Million Marketed Convertible Senior Notes Offering, Concurrent Equity Placement and Concurrent Delta Repurchase

Indeterminate GlobeNewswire

Sep. 9, 2026

CoinShares CEO Jean-Marie Mognetti to Attend Oppenheimer Fintech Leaders Conference in New York

Indeterminate GlobeNewswire

Sep. 9, 2026

Radiopharm Theranostics Announces Positive Data from the Phase 1 Imaging Trial of RAD301 in Patients with Pancreatic Ductal Adenocarcinoma

Indeterminate GlobeNewswire

Sep. 9, 2026

Balchem Corporation to Participate in the 9th Annual Wells Fargo Consumer Conference on September 23, 2026

Indeterminate GlobeNewswire

Sep. 9, 2026

Remix Therapeutics Appoints Nicole Sweeny as Chief Commercial Officer

Indeterminate GlobeNewswire

Sep. 9, 2026

Accumulus Technologies Announces Acquisition by Eir Partners to Accelerate Next Phase of Growth

Indeterminate GlobeNewswire

Sep. 9, 2026

Satellos Announces Forazapadin as Assigned International Nonproprietary Name for Lead Drug Candidate, SAT-3247

Indeterminate GlobeNewswire

Sep. 9, 2026

Fractyl Health to Participate in Upcoming September Investor Conferences

Indeterminate GlobeNewswire

Sep. 9, 2026

SailPoint Announces Fiscal Second Quarter 2027 Results

Indeterminate GlobeNewswire

Sep. 9, 2026

Onco360® Has Been Selected as Part of an Ultra-Narrow Specialty Pharmacy Network for MIMRYLO™ (rusfertide)

Indeterminate GlobeNewswire